We found reduced immunohistochemical PPARγ expression in EC, which is consistent with other reports showing rather moderate immunoreactivity of PPARγ expression in endometrial carcinoma cells [14, 15]. The gene discussed is PPARG; the disease is endometrial carcinoma.